Tweets
#ACR22 - Day 1
https://t.co/GlEhTnKXm7 https://t.co/JFyMSpjFq3
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
JAK vs TNF inhibitor Infections in RA
Dr. David Liew ( @drdavidliew) discusses abstract 0302 at #ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
https://t.co/ipD5ON7BJ7 https://t.co/rRD5wqHhFk
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
#ACR22 Appraisal, Praise & Critique
Dr. Cush talks ACR22, the highs and the lows.
https://t.co/1SVr2LLOcG https://t.co/PqcMix7O1f
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Retrospective review of 265 ILD pts - 9.8% were ANCA positive (PR3, MPO). ANCA- oft called IPF. ANCA+ CTD-ILD and 65% evolved into AAV (29% AAV follwed ILD Dx). No lung diff betw Pos v Neg pts, but ANCA+ had more drugs, hosp. #ACR22 https://t.co/X6UfiawfmW https://t.co/BZpTsjYAFW
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Breakthrough COVID infection in SLE during Omicron era
Dr. Yusof ( @Yuz6Yusof) talks with Dr. Amit Saxena about abstract #2081 at #ACR22
Abstract 2081: COVID-19 Infections, Morbidity, and Seroreactivity in SLE Patients....
https://t.co/0OFcHK2PLj https://t.co/2ULOfSZUqU
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Opioids and Health Care Utilization in PsA and AS
Dr Aurelie Najm ( @AurelieRheumo) discusses Abstract 0402 presented at #ACR22. Abstract 0402: Opioid Use and Healthcare Utilization in Adults with PsA and AS
https://t.co/trruZGyIVf https://t.co/8kj9vpKPlD
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Dr. Ted Mikuls has authored a Clinical practive review of Gout in this weeks New England Journal of Medicine - Congrats Ted! https://t.co/8MuC6upkOT https://t.co/zO4nZbWQ5A
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Retrospective review of 185 hospitalized AOSD pts (incidence 0.16 - 0.21/100K); Mean age 47 (70% female), mean ESR 55, CRP 12.26, ferritin 7141 WBC 12.15, anemia 23%. 24% ICU care & overall mortality was 3.2%. Ab#0829 #ACR22 https://t.co/eDRY4b3GAg https://t.co/3pt0ZH5QQH
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Best of PsA on Day 1
Dr. Rachel Tate ( @uptoTate) discusses the best PSA data presented 11/12 at #ACR22
https://t.co/i93CX7wic3 https://t.co/dQDOcIsu1P
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
#ACR22 - Day 2 Part III
RheumNow and its reporters review abstracts presented on Day 2 of #ACR22.
https://t.co/uUiX7s5Ajf https://t.co/0E5KSpOyyL
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Survival and Mortality in RA: time to move away from “one-size fits all”?
Dr. Aurelie Najm ( @AurelieRheumo ) reviews Abstract #0246 at #ACR22.
https://t.co/O4dNzCZmmd https://t.co/cWUXEpduID
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Exciting Data for SLE: Plenaries from #ACR22
Dr. Michael Putman ( @EBRheum ) shares SLE updates shared at #ACR22.
https://t.co/34HAvc2S8F https://t.co/xINo52fF2O
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
